BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2015
View Archived Issues
Regen Bio develops depot local delivery of CTCFL-targeting siRNA for liver cancer
Read More
Ocata receives NIH grant to develop photoreceptor cell therapy for retinal degenerative diseases
Read More
Adaptimmune expands phase I/II trial of NY-ESO TCR therapeutic in synovial sarcoma
Read More
MediWound completes enrollment in second phase II trial of EscharEx
Read More
Janssen discloses new GPR120 agonists for diabetes
Read More
MicroRNA panel may allow earlier diagnosis of pancreatic cancer
Read More
Innocoll initiates first phase III trial of XaraColl
Read More
Daiichi Sankyo licenses Japanese rights to MedImmune's FluMist Quadrivalent
Read More
Bristol-Myers Squibb discloses new gamma-secretase modulators for AD
Read More
Vaxin changes name to Altimmune
Read More
Sandoz launches the first biosimilar in the U.S.
Read More
Acadia submits NDA for Nuplazid for Parkinson's disease psychosis
Read More
GSK discloses IFN-alpha inducers
Read More
Bayer presents novel dual sGC activators and PDE5 inhibitors
Read More
Takeda patents OX1 receptor antagonists
Read More
Bristol-Myers Squibb presents macrocyclic HIV integrase inhibitors
Read More
Frost Biologic discloses new antimitotics
Read More
First launch planned for Acoalan in Japan
Read More
FDA grants breakthrough therapy designation to ACE-910 for hemophilia A
Read More
Tetraphase's TP-271 receives FDA QIDP and fast track designations
Read More
FDA accepts sBLA filing for Opdivo in previously treated non-squamous NSCLC
Read More
Merck & Co. divulges A2A receptor antagonists
Read More
Sanofi terminates option to license Ardelyx's RDX-002 program
Read More
Cure Duchenne provides funds to MyoTherix to advance promising DMD research
Read More
Remestemcel-L recommended for approval in Japan
Read More
Amgen reports new BACE1 inhibitors for the treatment of AD
Read More